ArticleRMD open2018

Does a mandatory non-medical switch from originator to biosimilar infliximab lead to increased use of outpatient healthcare resources? A register-based study in patients with inflammatory arthritis.

Bente Glintborg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.